Nu-Med Grupa S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nu-Med Grupa S.A. - overview
Established
2013
Location
Elblag, -, Poland
Primary Industry
Healthcare Specialists
About
Based in Elblag, Poland, and founded in 2013, Nu-Med Grupa S. A. operates as a provider of clinics and outpatient services for patients to improve early detection, diagnosis, and radiotherapy. In August 2024, Affidea B.
V. , a portfolio company of Groupe Bruxelles Lambert, acquired Nu-Med Grupa S. A. Nu-Med Grupa S.
A. provides various services such as radiotherapy, clinical oncology, oncological surgery, diagnostic clinics, clinical trials, drug programs, non-oncological treatment, patient support in therapy, and pharmacy support. The company offers National health fund support for patients to provide free-of-charge services in its hospitals. As of 2024, it operates in various locations such as the radiotherapy and oncology center – Elblag, oncology diagnostics and therapy center – Katowice, specialist oncology hospital - Tomaszow Mazowiecki, oncology diagnostics and therapy center – Zamosc, and many more.
Current Investors
Enterprise Investors
Primary Industry
Healthcare Specialists
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Clinics/Outpatient Services, Oncology/Cancer Treatment
Website
www.nu-med.pl
Company Stage
Buyout
Total Amount Raised
Subscriber access only
Nu-Med Grupa S.A. - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 25,627,200 | 111,238,000 | 130,464,000 | 148,078,000 | - | - | - |
| % Revenue Growth (YoY) | - | 334.1% | 17.3% | 13.5% | - | - | - |
| EBITDA (USD) | 3,168,400 | - | - | 7,646,000 | - | - | - |
| Operating Income (USD) | (3,793,900) | - | - | (14,013,000) | - | - | - |
| Operating Margin | (14.8%) | - | - | (9.5%) | - | - | - |
| % EBITDA Margin | 12.4% | - | - | 5.2% | - | - | - |
| NET Income (USD) | (16,298,800) | 43,672,000 | 65,833,000 | (73,176,000) | - | - | - |
| % Net Margin | (63.6%) | 39.3% | 50.5% | (49.4%) | - | - | - |
Nu-Med Grupa S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Nu-Med Grupa S.A. | - | ||||||||
| Private Debt | Completed | Nu-Med Grupa S.A. | - | ||||||||
| Merger | Completed | Radiotherapy Centre Poland | - | ||||||||
| Buyout | Completed | Nu-Med Grupa S.A. | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.